tiprankstipranks
Trending News
More News >
Paltac Corporation (JP:8283)
:8283
Advertisement

Paltac (8283) AI Stock Analysis

Compare
0 Followers

Top Page

JP:8283

Paltac

(OTC:8283)

Rating:73Outperform
Price Target:
¥4,507.00
▲(6.05%Upside)
Paltac's strong financial performance, characterized by low leverage, high equity, and efficient cash management, is a key strength. The valuation is attractive with a reasonable P/E ratio and solid dividend yield. However, technical analysis is mixed, indicating some uncertainty in stock momentum. Overall, Paltac is well-positioned within its industry, offering a balanced investment opportunity with solid financials, though technical indicators suggest caution.

Paltac (8283) vs. iShares MSCI Japan ETF (EWJ)

Paltac Business Overview & Revenue Model

Company DescriptionPaltac Corporation is a leading Japanese wholesale distributor specializing in the distribution of cosmetics, daily necessities, and over-the-counter (OTC) pharmaceuticals. The company primarily serves the retail sector, providing a wide array of products to supermarkets, drugstores, and convenience stores across Japan. With its extensive logistics network and advanced distribution systems, Paltac ensures efficient and timely delivery of products, maintaining strong relationships with both suppliers and retailers.
How the Company Makes MoneyPaltac makes money through the wholesale distribution of cosmetics, daily necessities, and OTC pharmaceuticals. The company purchases products directly from manufacturers and sells them in bulk to a variety of retail clients. Its revenue model is driven by the margin between the purchase price from manufacturers and the selling price to retailers. Paltac's significant revenue streams include sales to large retail chains, which benefit from the company's extensive logistics and distribution network. The company enhances its earnings through strategic partnerships with major manufacturers and retailers, ensuring a steady supply and demand for its products. Additionally, Paltac invests in logistics technology to optimize its supply chain, thereby reducing costs and improving profitability.

Paltac Financial Statement Overview

Summary
Paltac exhibits strong financial health across all verticals. The income statement reflects consistent revenue and profit growth, supported by stable margins. The balance sheet is characterized by low leverage and high equity, indicating financial stability. Cash flow analysis shows efficient cash generation and management. The overall financial position is solid, with a well-balanced growth trajectory and low financial risk, positioning Paltac well in the Household & Personal Products industry.
Income Statement
82
Very Positive
Paltac has demonstrated strong revenue growth over the recent years with a notable revenue growth rate of 3.14% in the latest year. The gross profit margin remains stable around 7.15%, while the net profit margin has improved to 1.92%. The company's EBIT and EBITDA margins, at 2.52% and 3.30% respectively, indicate efficient operational management. Overall, the income statement reflects robust financial health with consistent growth and improving profitability.
Balance Sheet
78
Positive
The balance sheet of Paltac shows a strong equity position with a debt-to-equity ratio of 0.0012, suggesting low leverage and financial stability. The return on equity stands at 7.95%, highlighting efficient use of equity to generate profits. The equity ratio is healthy at 56.73%, indicating that a substantial portion of the company's assets are financed by shareholders' equity. These metrics illustrate a solid financial footing and low financial risk.
Cash Flow
85
Very Positive
Paltac's cash flow statements reveal a positive trend with a free cash flow growth rate of -8.18% due to temporary fluctuations in capital expenditures. The operating cash flow to net income ratio is 0.90, indicating strong cash generation relative to net income. The free cash flow to net income ratio of 0.84 further emphasizes efficient cash management. Overall, the cash flow position is robust, with consistent generation of free cash flow and effective capital allocation.
Breakdown
Income Statement
Total Revenue
Gross Profit
EBITDA
Net Income
Balance Sheet
Total Assets
Cash, Cash Equivalents and Short-Term Investments
Total Debt
Total Liabilities
Stockholders Equity
Cash Flow
Free Cash Flow
Operating Cash Flow
Investing Cash Flow
Financing Cash Flow

Paltac Technical Analysis

Technical Analysis Sentiment
Positive
Last Price4250.00
Price Trends
50DMA
4082.10
Positive
100DMA
4015.41
Positive
200DMA
4112.28
Positive
Market Momentum
MACD
36.06
Negative
RSI
63.96
Neutral
STOCH
66.16
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:8283, the sentiment is Positive. The current price of 4250 is above the 20-day moving average (MA) of 4103.00, above the 50-day MA of 4082.10, and above the 200-day MA of 4112.28, indicating a bullish trend. The MACD of 36.06 indicates Negative momentum. The RSI at 63.96 is Neutral, neither overbought nor oversold. The STOCH value of 66.16 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:8283.

Paltac Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
¥492.18B15.5812.05%1.70%13.95%0.37%
73
Outperform
¥265.93B11.657.98%2.46%3.14%11.57%
69
Neutral
$282.84B37.874.49%4.07%-0.74%-25.66%
68
Neutral
¥195.96B21.388.29%2.27%4.94%1.21%
63
Neutral
$330.49B56.422.08%2.42%4.63%-60.17%
59
Neutral
$397.87B18.697.58%1.98%2.30%33.87%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:8283
Paltac
4,269.00
-252.12
-5.58%
JP:4527
Rohto Pharmaceutical Co
2,120.00
-1,368.88
-39.24%
JP:4927
Pola Orbis Holdings
1,279.00
-84.44
-6.19%
JP:4922
Kose
5,701.00
-4,062.70
-41.61%
JP:4912
Lion
1,466.00
193.58
15.21%

Paltac Corporate Events

PALTAC Emphasizes Independence and Governance in Parent Company Relationship
Jun 20, 2025

PALTAC CORPORATION has announced its relationship with its parent company, MEDIPAL HOLDINGS CORPORATION, emphasizing its independence in business operations and governance. The company has implemented measures to protect minority shareholders and ensure fair transactions with its controlling shareholder, maintaining a balance between autonomy and group governance.

Paltac Corporation Announces Steady Financial Growth for FY 2025
May 26, 2025

Paltac Corporation reported its financial results for the fiscal year ending March 31, 2025, showing a modest increase in net sales and profits compared to the previous year. The company experienced a 3.1% rise in net sales to ¥1,188,097 million and a 10.8% increase in profit to ¥22,864 million. The financial position remains stable with a slight increase in total assets and net assets, and a higher dividend payout is planned for the next fiscal year. These results indicate a steady growth trajectory and a commitment to returning value to shareholders.

Paltac Corporation Reports Strong Fiscal Year Performance with Increased Profits and Dividends
May 12, 2025

Paltac Corporation reported a 3.1% increase in net sales and a 10.8% rise in profit for the fiscal year ending March 31, 2025, indicating strong operational performance. The company also announced a higher annual dividend, reflecting confidence in its financial health and commitment to shareholder returns.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jul 05, 2025